The CANTOS study demonstrated that anti-inflammatory interventions can reduce the risk of coronary events. Among the many different inflammatory pathways, which one should be targeted? The challenges of proving each inflammatory hypothesis are discussed by Milton Packer (Baylor Heart and Vascular Institute Baylor University Medical Center, Dallas) at ESC18 , the annual meeting of European Society of Cardiology.